Catalog No.:AA00EA9A

5689-59-8 | N-Adamantan-1-yl-2-chloro-acetamide

Name: Name:N-Adamantan-1-yl-2-chloro-acetamide
Brand: AABLOCKS
SKU: AA00EA9A
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

500mg

>95%

2 weeks

$552.00 $386.00

- +

>95%

2 weeks

$582.00 $408.00

- +

>95%

2 weeks

$898.00 $629.00

- +

10g

>95%

2 weeks

$1,286.00 $900.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA00EA9A

Chemical Name:

N-Adamantan-1-yl-2-chloro-acetamide

CAS Number:

5689-59-8

Molecular Formula:

C12H18ClNO

Molecular Weight:

227.7304

MDL Number:

MFCD01733430

SMILES:

ClCC(=O)N[C@]12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3

Properties

BP:

385.3°C at 760 mmHg

Form:

Solid

MP:

120-121℃

Storage:

Keep in dry area;2-8℃;

Computed Properties

Complexity:

248

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

2.8

Downstream Synthesis Route

665-66-7

79-04-9

5689-59-8

[1]EuropeanJournalofMedicinalChemistry,2010,vol.45,p.2075-2079

[2]Patent:JP5879228,2016,B2.Locationinpatent:Paragraph0055;0056

[3]IlFarmaco,1993,vol.48,p.1021-1049

[4]Journalofmedicinalchemistry,1971,vol.14,p.535-543

768-94-5

79-04-9

5689-59-8

[1]Locationinpatent:schemeortableGiordanetto,Fabrizio;Knerr,Laurent;Selmi,Nidhal;Llins,Antonio;Lindqvist,Anders;Wang,Qing-Dong;Sthlberg,Pernilla;Thorstensson,Fredrik;Ullah,Victoria;Nilsson,Kristina;O'Mahony,Gavin;Hoegberg,Got;Lindhardt,Emma;Strand,Annika;Duker,Goeran[BioorganicandMedicinalChemistryLetters,2011,vol.21,#18,p.5557-5561]

[2]Avdyunina,N.I.;Morozov,I.S.;Bol'shakova,R.F.;Militareva,N.A.;Klimova,N.V.;etal.[PharmaceuticalChemistryJournal,1988,vol.22,#7,p.543-546][Khimiko-FarmatsevticheskiiZhurnal,1988,vol.22,#7,p.819-822]

[3]CurrentPatentAssignee:CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN110498761,2019,ALocationinpatent:Paragraph0071-0074

[4]Paczal,Attila;Benyei,AttilaC.;Kotschy,Andras[JournalofOrganicChemistry,2006,vol.71,#16,p.5969-5979]

[5]Grabrijan,Katarina;Hrast,Martina;Proj,Matic;Dolšak,Ana;Zdovc,Irena;Imre,Tímea;Petri,László;Ábrányi-Balogh,Péter;Keserű,GyörgyM.;Gobec,Stanislav[EuropeanJournalofMedicinalChemistry,2022,vol.243]

[6]Grabrijan,Katarina;Hrast,Martina;Proj,Matic;Dolšak,Ana;Zdovc,Irena;Imre,Tímea;Petri,László;Ábrányi-Balogh,Péter;Keserű,GyörgyM.;Gobec,Stanislav[EuropeanJournalofMedicinalChemistry,2022,vol.243]

[7]Collinson,John-Michael;Wilton-Ely,JamesD.E.T.;Diez-Gonzalez,Silvia[ChemicalCommunications,2013,vol.49,#97,p.11358-11360]

[8]Fischer,Christian;Vepřek,NynkeA.;Peitsinis,Zisis;Rühmann,Klaus-Peter;Yang,Chao;Spradlin,JessicaN.;Dovala,Dustin;Nomura,DanielK.;Zhang,Yingkai;Trauner,Dirk[Synlett,2021,vol.33,#5,p.458-463]

[9]CurrentPatentAssignee:BRANDEISUNIVERSITY-US2005/43353,2005,A1Locationinpatent:Page/Pagecolumn28

[10]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-US2013/35325,2013,A1Locationinpatent:Paragraph0455;0456

[11]Sokolov;Aksinenko,A.Yu.;Epishina;Goreva[RussianChemicalBulletin,2018,vol.67,#8,p.1401-1405][Izv.Akad.Nauk,Ser.Khim.,2018,vol.67,#8,p.1401-1405,5]

[12]Švajger,Urban;Bratkovič,Tomaž;Dolšak,Ana;Gobec,Stanislav;Mlinarič,Larisa;Ogorevc,Eva;Sova,Matej[Pharmaceuticals,2021,vol.14,#3]

5689-59-8

109635-38-3

N-Adamantan-1-yl-2-3-(4-chloro-benzyl)-2-imino-2,3-dihydro-benzoimidazol-1-yl-acetamide

[1]DaSettimo;Marini;Primofiore;DaSettimo[IlFarmaco,1995,vol.50,#5,p.321-326]

593-71-5

4411-25-0

5689-59-8

[1]Pace,Vittorio;Castoldi,Laura;Holzer,Wolfgang[ChemicalCommunications,2013,vol.49,#75,p.8383-8385]

[2]Pace,Vittorio;Castoldi,Laura;Mamuye,AshenafiDamtew;Holzer,Wolfgang[Synthesis,2014,vol.46,#21,p.2897-2909]

5689-59-8

79-39-0

N-(2-(1-adamantylamino)-2-oxoethyl)methacrylamide

[1]Patent:JP5879228,2016,B2.Locationinpatent:Paragraph0058;0059

Literature

Title: N-(Adamantan-1-yl)-2-chloro-acetamide.

Journal: Acta crystallographica. Section E, Structure reports online 20110601

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS